Create ppt - Sepsis management with recent guidelines
Reading File
Reading File
Reading File
Finding Sources
Searching PubMed
"sepsis" AND "management guidelines"
Searching the Web
Surviving Sepsis Campaign guidelines 2024 2025 updates
Reading File
Reading Web Page
sepsis management guidelines 2026 recommendations
Finding Sources
Reading File
Reading Web Page
sepsis 2026 guidelines key recommendations vasopressors antibiotics fluid resuscitation
Running Command
Writing File
Running Command
Running Command
Your presentation is ready!
Sepsis Management 2026
Presentation · PPTX
What's inside (26 slides)
| # | Slide | Content |
|---|---|---|
| 1 | Title Slide | Branded cover with SSC 2026 citation |
| 2 | Overview | 10-topic agenda with color-coded tiles |
| 3–5 | Definitions & SOFA | Sepsis-3 definitions, SOFA score full table |
| 6–7 | Pathophysiology | PAMPs/DAMPs → cytokine storm → organ failure cascade |
| 8–9 | Early Recognition | qSOFA criteria, NEWS2, MEWS, AI-TREWS compared |
| 10–11 | 1-Hour Bundle | 5 action steps with timing (SSC 2026) |
| 12–13 | Fluid Resuscitation | 30 mL/kg crystalloid, MAP targets 60–70, de-resuscitation |
| 14–15 | Antimicrobial Therapy | Timing table by infection site, CAP/HAP/VAP regimens |
| 16–17 | Vasopressors & Steroids | NE → vasopressin → epi ladder; hydrocortisone 200 mg/day |
| 18–19 | Ventilation & Supportive Care | Lung-protective ventilation, SDD, glucose control, nutrition |
| 20–21 | Source Control & De-escalation | 6-12h target, PCT-guided antibiotic narrowing |
| 22–23 | 2026 SSC Key Updates | 10 NEW/UPDATED/UNCHANGED tagged recommendations |
| 24 | Management Timeline | T=0, <1h, 1–6h, >6h visual flow |
| 25 | Outcomes & PICS | Mortality stats, post-sepsis syndrome |
| 26 | References | 8 key citations including SSC 2026, Harrison's 22E |
Notable 2026 SSC updates highlighted
- MAP target range of 60–70 mmHg (not fixed 65)
- SDD now recommended for mechanically ventilated patients
- Active fluid removal (de-resuscitation) in later shock phases
- Discourage empiric antifungal and anaerobic cover when suspicion is low
- Peripheral IV vasopressor initiation supported
This is a shared conversation. Sign in to Orris to start your own chat.